================================================================================
EXHIBIT  31.1


CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
- -----------------------------------------------------------------------

I,  Diane  Dottavio,  certify  that:

1.   I  have  reviewed  this  quarterly report on Form 10-QSB of Endovasc, Inc.;

2.   Based  on  my  knowledge,  this  report  does  not  contain  any  untrue
     statement  of a material fact or omit to state a material fact necessary to
     make  the  statements  made, in light of the circumstances under which such
     statements  were made, not misleading with respect to the period covered by
     this report;

3.   Based  on  my  knowledge,  the  financial  statements,  and other financial
     information  included  in  this  report,  fairly  present  in  all material
     respects  the  financial condition, results of operations and cash flows of
     Endovasc, Inc. as of, and for, the periods presented in this report;

4.   Endovasc, Inc.'s. other certifying officer and I:

     (a)  are  responsible  for  establishing  and  maintaining  disclosure
     controls  and  procedures  (as  defined in Exchange Act Rules 13a-15(e) and
     15d-15(e)) for Endovasc, Inc. and have:

     (b)  Designed  such  disclosure  controls  and  procedures,  or caused such
     disclosure controls and procedures to be designed under our supervision, to
     ensure  that material information relating to Endovasc, Inc., including its
     consolidated  subsidiaries,  is  made  known  to  us by others within those
     entities,  particularly  during  the  period  in which this report is being
     prepared;

     (c)  Evaluated  the  effectiveness  of  Endovasc,  Inc.'s  disclosure
     controls  and procedures and presented in this report our conclusions about
     the  effectiveness of the disclosure controls and procedures, as of the end
     of the period covered by this report based on such evaluation; and

     (d)  Disclosed  in  this  report  any  change  in Endovasc, Inc.'s internal
     control over financial reporting that occurred during Endovasc, Inc.'s most
     recent fiscal quarter that has materially affected, or is reasonably likely
     to  materially  affect,  Endovasc,  Inc.'s  internal control over financial
     reporting; and

5.   Endovasc,  Inc.'s  other  certifying  officer  and  I have disclosed, based
     on our most recent evaluation of internal control over financial reporting,
     to  Endovasc,  Inc.'s  auditors and the audit committee of Endovasc, Inc.'s
     board of directors (or persons performing the equivalent functions):

     (a)  All  significant  deficiencies  and  material weaknesses in the design
     or  operation  of  internal  control  over  financial  reporting  which are
     reasonably  likely  to adversely affect Endovasc, Inc.'s ability to record,
     process, summarize and report financial information; and

     (b)  Any  fraud,  whether  or  not  material,  that  involves management or
     other  employees  who  have a significant role in Endovasc, Inc.'s internal
     control over financial reporting.

Date:  May 20, 2005                         By:  /s/ Diane Dottavio
                                                 ------------------
                                                     Diane Dottavio
                                                     Chief Executive Officer